Kevin DeGeeter's Stock Ratings

Oppenheimer Analyst

Kevin DeGeeter is an analyst at Oppenheimer. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/27/2025

Overall Average Return

52.2%

Smart Score

65.8%

Overall Average Return Percentile

95th

Number of Ratings

68
Buy NowGet Alert
08/09/2023ORTXBuy Now
Orchard Therapeutics
——
Kevin DeGeeter65%
→ $34ReiteratesOutperform → OutperformGet Alert
06/13/2023ORTXBuy Now
Orchard Therapeutics
——
Kevin DeGeeter65%
$37 → $34MaintainsOutperformGet Alert
04/19/2022ANTXBuy Now
AN2 Therapeutics
$1.501366.57%
Kevin DeGeeter65%
→ $22Initiates → OutperformGet Alert
03/22/2022ORICBuy Now
ORIC Pharmaceuticals
$6.19—
Kevin DeGeeter65%
—DowngradeOutperform → PerformGet Alert
02/25/2022PSNLBuy Now
Personalis
$3.60567.59%
Kevin DeGeeter65%
$30 → $24MaintainsOutperformGet Alert
02/02/2022NVCRBuy Now
NovoCure
$18.86419.76%
Kevin DeGeeter65%
→ $98UpgradePerform → OutperformGet Alert
01/25/2022FLGTBuy Now
Fulgent Genetics
$16.88640.74%
Kevin DeGeeter65%
$141 → $125MaintainsOutperformGet Alert
11/29/2021MDXHBuy Now
MDxHealth
$1.581039.24%
Kevin DeGeeter65%
→ $18Initiates → OutperformGet Alert
11/19/2021SERABuy Now
Sera Prognostics
$3.55435.21%
Kevin DeGeeter65%
→ $19Initiates → OutperformGet Alert
11/05/2021ORTXBuy Now
Orchard Therapeutics
——
Kevin DeGeeter65%
$150 → $130MaintainsOutperformGet Alert
10/01/2021SPROBuy Now
Spero Therapeutics
$0.78—
Kevin DeGeeter65%
—DowngradeOutperform → PerformGet Alert
09/21/2021PRTGBuy Now
Portage Biotech
$9.76207.32%
Kevin DeGeeter65%
→ $600Initiates → OutperformGet Alert
08/24/2021PANWBuy Now
Palo Alto Networks
$172.09176.02%
Kevin DeGeeter65%
$75 → $79.17MaintainsOutperformGet Alert
07/29/2021EXASBuy Now
Exact Sciences
$43.76254.2%
Kevin DeGeeter65%
$161 → $155MaintainsOutperformGet Alert
06/29/2021SNSEBuy Now
Sensei Biotherapeutics
$0.56—
Kevin DeGeeter65%
—DowngradeOutperform → PerformGet Alert
05/27/2021RZLTBuy Now
Rezolute
$2.96746.02%
Kevin DeGeeter65%
→ $25Initiates → OutperformGet Alert
05/07/2021HGENBuy Now
Humanigen
——
Kevin DeGeeter65%
→ $30Initiates → OutperformGet Alert
05/06/2021PSNLBuy Now
Personalis
$3.60678.86%
Kevin DeGeeter65%
→ $28UpgradePerform → OutperformGet Alert
04/30/2021CYCCBuy Now
Cyclacel Pharmaceuticals
$0.325164.79%
Kevin DeGeeter65%
→ $255Initiates → OutperformGet Alert
04/05/2021NVTABuy Now
Invitae
——
Kevin DeGeeter65%
→ $48UpgradePerform → OutperformGet Alert
03/02/2021EVAXBuy Now
Evaxion Biotech
$1.69965.09%
Kevin DeGeeter65%
→ $1800Initiates → OutperformGet Alert
03/02/2021ATNXBuy Now
Athenex
——
Kevin DeGeeter65%
—DowngradeOutperform → PerformGet Alert
03/01/2021SNSEBuy Now
Sensei Biotherapeutics
$0.566289.78%
Kevin DeGeeter65%
→ $36Initiates → OutperformGet Alert
02/01/2021FLGTBuy Now
Fulgent Genetics
$16.88670.37%
Kevin DeGeeter65%
$75 → $130MaintainsOutperformGet Alert
02/01/2021NVTABuy Now
Invitae
——
Kevin DeGeeter65%
—DowngradeOutperform → PerformGet Alert
01/29/2021NMTRBuy Now
9 Meters Biopharma
——
Kevin DeGeeter65%
→ $120Initiates → OutperformGet Alert
01/22/2021DMTKBuy Now
DermTech
——
Kevin DeGeeter65%
→ $53Initiates → OutperformGet Alert
01/11/2021VCELBuy Now
Vericel
$44.80—
Kevin DeGeeter65%
—DowngradeOutperform → PerformGet Alert
01/05/2021TSHABuy Now
Taysha Gene Therapies
$1.93—
Kevin DeGeeter65%
—Initiates → OutperformGet Alert
12/08/2020RCKTBuy Now
Rocket Pharmaceuticals
$7.62—
Kevin DeGeeter65%
—DowngradeOutperform → PerformGet Alert
11/06/2020PSNLBuy Now
Personalis
$3.60—
Kevin DeGeeter65%
—DowngradeOutperform → PerformGet Alert
08/20/2020FLGTBuy Now
Fulgent Genetics
$16.88344.44%
Kevin DeGeeter65%
→ $75Initiates → OutperformGet Alert
07/01/2020CLRBBuy Now
Cellectar Biosciences
$0.361288.89%
Kevin DeGeeter65%
→ $50Initiates → OutperformGet Alert
05/01/2020NVCRBuy Now
NovoCure
$18.86313.68%
Kevin DeGeeter65%
$102 → $78DowngradeOutperform → PerformGet Alert
04/17/2020VBLTBuy Now
Vascular Biogenics
——
Kevin DeGeeter65%
$70 → $105MaintainsOutperformGet Alert
04/08/2020BNGOBuy Now
Bionano Genomics
$3.19-52.98%
Kevin DeGeeter65%
→ $900Initiates → OutperformGet Alert
01/16/2020IDXGBuy Now
Interpace Biosciences
$1.151378.26%
Kevin DeGeeter65%
$2 → $17MaintainsOutperformGet Alert
12/09/2019RCKTBuy Now
Rocket Pharmaceuticals
$7.62451.18%
Kevin DeGeeter65%
$36 → $42MaintainsOutperformGet Alert
09/26/2019EXASBuy Now
Exact Sciences
$43.76197.07%
Kevin DeGeeter65%
→ $130Initiates → OutperformGet Alert
08/13/2019RCKTBuy Now
Rocket Pharmaceuticals
$7.62385.56%
Kevin DeGeeter65%
$39 → $37MaintainsOutperformGet Alert
07/15/2019PSNLBuy Now
Personalis
$3.60706.68%
Kevin DeGeeter65%
→ $29Initiates → OutperformGet Alert
06/28/2019NVCRBuy Now
NovoCure
$18.86297.77%
Kevin DeGeeter65%
→ $75Initiates → OutperformGet Alert
06/27/2019VBLTBuy Now
Vascular Biogenics
——
Kevin DeGeeter65%
→ $70Initiates → OutperformGet Alert
05/02/2019ATNXBuy Now
Athenex
——
Kevin DeGeeter65%
→ $400Initiates → OutperformGet Alert
02/05/2019RCKTBuy Now
Rocket Pharmaceuticals
$7.62411.81%
Kevin DeGeeter65%
→ $39Initiates → OutperformGet Alert
01/29/2019VCELBuy Now
Vericel
$44.80-48.65%
Kevin DeGeeter65%
→ $23Initiates → OutperformGet Alert
06/13/2018GHDXBuy Now
Genomic Health
——
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
12/26/2017RXDXBuy Now
Prometheus Biosciences
——
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
11/20/2017ABLXBuy Now
Ablynx NV - American Depositary Shares
——
Kevin DeGeeter65%
→ $30Initiates → BuyGet Alert
08/09/2017NVAXBuy Now
Novavax
$7.08—
Kevin DeGeeter65%
—UpgradeNeutral → BuyGet Alert
08/04/2017CBMXBuy Now
CombiMatrix
——
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
08/03/2017MTEMBuy Now
Molecular Templates
$0.00999999900%
Kevin DeGeeter65%
→ $150Initiates → BuyGet Alert
06/06/2017CBIOBuy Now
Catalyst Biosciences
——
Kevin DeGeeter65%
→ $165Initiates → BuyGet Alert
04/12/2017CDTXBuy Now
Cidara Therapeutics
$21.92-48.68%
Kevin DeGeeter65%
→ $225Initiates → BuyGet Alert
02/08/2017MYGNBuy Now
Myriad Genetics
$8.79—
Kevin DeGeeter65%
—UpgradeSell → NeutralGet Alert
01/04/2017CDXSBuy Now
Codexis
$2.83—
Kevin DeGeeter65%
—UpgradeNeutral → BuyGet Alert
12/29/2016CEMPBuy Now
Cempra
——
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
12/09/2016ILBuy Now
IntraLinks Holdings
——
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
10/10/2016MYGNBuy Now
Myriad Genetics
$8.79—
Kevin DeGeeter65%
—DowngradeNeutral → SellGet Alert
10/04/2016VNRBuy Now
Vanguard Natural Res
——
Kevin DeGeeter65%
—DowngradeNeutral → SellGet Alert
10/03/2016TASRBuy Now
Taser International
——
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
09/16/2016NVAXBuy Now
Novavax
$7.08—
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
09/06/2016CLCDBuy Now
CoLucid Pharmaceuticals
——
Kevin DeGeeter65%
$23 → $52MaintainsBuyGet Alert
03/04/2015CDXSBuy Now
Codexis
$2.83—
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
02/05/2014MYGNBuy Now
Myriad Genetics
$8.79—
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
10/01/2013MYGNBuy Now
Myriad Genetics
$8.79—
Kevin DeGeeter65%
—UpgradeNeutral → BuyGet Alert
02/05/2013MYGNBuy Now
Myriad Genetics
$8.79—
Kevin DeGeeter65%
—DowngradeBuy → NeutralGet Alert
05/03/2012GHDXBuy Now
Genomic Health
——
Kevin DeGeeter65%
$32 → $33MaintainsBuyGet Alert